Abstract:Background: Diabetes mellitus is one of the common metabolic disorders that have high morbidity. Diabetic patients are prone to developing chronic nonhealing foot ulcers, a leading cause of limb amputations. Autologous platelet-rich plasma (PRP) contains proteins rich in multiple growth factors (GFs) used in treating chronic diabetic foot ulcers and helps in early tissue repair and regeneration. This study aimed to evaluate the safety and enhanced efficacy of autologous PRP, in the healing rate of chronic diabetic foot ulcers. Methodology: This was a randomized control open clinical study of 18-month duration involving 50 patients in each group. Patients admitted with type 2 diabetes mellitus–with hemoglobin A1c >6.5 and chronic healing long-standing ulcer of >1-month duration were included. Patients with severe anemia and cardiac illness, osteomyelitis were excluded as they are independent risk factors that affect ulcer healing. Admitted patients were randomly allocated to receive either PRP or normal saline dressings using computer-generated random numbers. Simple debridement was done to remove necrotic tissue on the day of admission before the first application of PRP or normal saline dressing. PRP was prepared after centrifugation of autologous whole blood (10 ml). In the study group, prepared and stored PRP (1–2 ml) was applied topically in drops using a syringe to cover the floor of the ulcer and covered with a sterile transparent dressing. In the control group, normal saline was soaked in the gauze and kept over the surface of the ulcer covered with a transparent dressing. The patient will receive dressings with PRP or saline according to the group they were placed in. Progress was monitored, and the dressing was changed every 3 rd day for up to 21 days. The wound area measurement was done by measuring the surface area of the wound with the help of a transparent sheet and graph. A transparent sheet was placed on the ulcer, and the total area of the ulcer was marked and recorded. The marked transparent sheet was placed over a graph sheet, and the outline was plotted. The area was calculated and recorded in cm 2 . The growth and healing of the wound are considered when a part of the wound shows an increase in granulation and a decrease in slough. Periodic photographs were taken on day 3, day 7, day 14, and day 21 and assessed. Two groups were compared for wound size reduction and duration of healing. The collected data were entered in Excel 2010 and measured using mean and standard deviation for continuous variables and in percentage for dichotomous and categorical variables. Two groups were compared using an independent t -test for continuous variables and a Chi-square test for dichotomous and categorical variables. Results: In our study on 100 patients, 50 in each group with ulcers of Wagner's Grade 1 and Grade 2, the appearance of granulation and size reduction rate is delayed with normal saline dressing (44/50 patients [88%]). In the autologous PRP dressing group, the rate of granulation from the 7 th day of dressing was greater (50/50, patients [100%]) and ulcer size reduction is statistically significant (Chi-square value 6.38, P < 0.001) when compared to normal saline. Conclusions: Autologous PRP used in chronic diabetic foot ulcer dressing enhances healing and shows a significant reduction in wound size over a shorter duration when compared with saline dressing. Autologous PRP is safe, efficient, and simple to prepare, providing necessary GFs to improve healing without adverse events.

Autologous platelet-rich plasma for treatment of chronic refractory wounds

Efficacy and safety of allogeneic platelet-rich plasma in chronic wound treatment: a meta-analysis of randomized controlled trials

[Follow-Up Study on Platelet-Rich Plasma in Repairing Chronic Wound Nonunion of Lower Limbs in 47 Cases].

Autologous Platelet-Rich Plasma Enhances Healing Of Chronic Wounds

A Prospective, Interventional, Comparative Study to Evaluate the Efficacy of Using Combined Platelet-Rich Plasma and Platelet-Rich Fibrin Over Standard Cleaning and Dressing in Chronic Wounds

Treatment of chronic non-healing ulcers using autologous platelet rich plasma: a case series

Effect of platelet-rich plasma on the treatment of hard agglut wounds

Effects of autologous platelet-rich plasma combined with negative pressure wound therapy for chronic refractory wounds: a Meta-analysis

Allogeneic Platelet-Rich Plasma Therapy as an Effective and Safe Adjuvant Method for Chronic Wounds.

Clinical observation of ultraviolet therapy combined with autologous platelet‐rich plasma in the treatment of chronic refractory wounds

Three Cases Using Platelet-Rich Plasma To Cure Chronic Soft Tissue Lesions

Efficacy of Local Autologous Platelet-Rich Plasma in the Treatment of Chronic Ulcer

The Preliminary Application of Autologous Platelet-rich Gel Used to Treat Refractory Diabetic Dermal Ulcer

Systematic literature review evaluating evidence and mechanisms of action for platelet-rich plasma as an antibacterial agent

Efficacy and Safety of Allogeneic Platelet Rich Plasma in Treatment of Diabetic Patients with Lower Limb Ulcers: A Pilot Study

Platelet-rich plasma accelerates skin wound healing by promoting re-epithelialization

Effectiveness of autologous platelet-rich plasma dressing in healing chronic diabetic foot ulcers in comparison with saline dressing. A randomized control study

Efficacy and Safety of Platelet-Rich Plasma for Patients with Diabetic Ulcers: A Systematic Review and Meta-analysis.

[Treatment of chronic refractory wound with autologous platelet-rich plasma in a hemophilia A patient after knee joint surgery]

Effectiveness of topical administration of platelet-rich plasma on the healing of methicillin-resistant Staphylococcus aureus-infected full-thickness wound model

Autologous Platelet‐rich Gel for Treatment of Diabetic Chronic Refractory Cutaneous Ulcers: A Prospective, Randomized Clinical Trial